![James Oliviero](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/05/2026
James F.
Oliviero is an Independent Director at Nuvectis Pharma, Inc. since 2021.
Formerly, Mr. Oliviero was President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. from 2018 to 2025.
Mr. Oliviero was Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
Mr. Oliviero was Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. in 2015.
Mr. Oliviero completed undergraduate studies at Goizueta Business School-Emory.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 0,46 % | 11/06/2026 | 122.828 ( 0,46 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NUVECTIS PHARMA, INC. | Director/Miembro de la Junta | 01/07/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Director Ejecutivo | 30/05/2025 |
| KERYX BIOPHARMACEUTICALS | Director Financiero/CFO | 01/09/2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Director Financiero/CFO | 01/05/2003 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
